Naga Venkata K. Pothineni

ORCID: 0000-0003-4908-2652
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Arrhythmias and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Cardiac pacing and defibrillation studies
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Imaging and Diagnostics
  • Coronary Interventions and Diagnostics
  • Cardiac Valve Diseases and Treatments
  • Acute Myocardial Infarction Research
  • Cardiovascular Syncope and Autonomic Disorders
  • Cardiac Structural Anomalies and Repair
  • Health Systems, Economic Evaluations, Quality of Life
  • ECG Monitoring and Analysis
  • Atherosclerosis and Cardiovascular Diseases
  • Mechanical Circulatory Support Devices
  • Cardiac Arrest and Resuscitation
  • Cardiovascular Function and Risk Factors
  • Venous Thromboembolism Diagnosis and Management
  • Infective Endocarditis Diagnosis and Management
  • Viral Infections and Immunology Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Heart Rate Variability and Autonomic Control
  • Cardiac tumors and thrombi
  • Heart Failure Treatment and Management
  • Cardiovascular Effects of Exercise
  • Central Venous Catheters and Hemodialysis

Heart Rhythm Society
2021-2025

Midwest Fertility Specialists
2024

University of Pennsylvania
2019-2023

University of Arkansas at Little Rock
2013-2022

Hospital of the University of Pennsylvania
2020-2022

Pennsylvania Hospital
2022

University of Arkansas for Medical Sciences
2012-2021

John L. McClellan Memorial Veterans Hospital
2021

Rutgers, The State University of New Jersey
2020

Robert Wood Johnson University Hospital
2020

Autonomic neuromodulation provides therapeutic benefit in ventricular tachycardia (VT) storm. Transcutaneous magnetic stimulation (TcMS) can noninvasively and nondestructively modulate a patient's nervous system activity may reduce VT burden patients with storm.To evaluate the safety efficacy of TcMS left stellate ganglion for storm.This double-blind, sham-controlled randomized clinical trial took place at single tertiary referral center between August 2019 July 2021. The study included 26...

10.1001/jamacardio.2021.6000 article EN JAMA Cardiology 2022-02-16

Abstract Background It is unclear if the location of implantation leadless pacemaker (LP) makes a difference in incidence pacing‐induced cardiomyopathy (PICM). Aim The aim this study was to compare PICM based on LP. Methods A total 358 consecutive patients [women: 171 (48%), mean age: 73 ± 15 years] with left ventricular ejection fraction (EF) > 50%, who received an LP (Micra) between January 2017 and June 2022, formed cohort. Micra‐AV Micra‐VR were implanted 122 (34%) 236 (66%) patients,...

10.1111/jce.15925 article EN Journal of Cardiovascular Electrophysiology 2023-05-10

Inpatient initiation of sotalol is recommended owing to its proarrhythmic effects.The DASH-AF (Feasibility and Safety Intravenous Sotalol Administered as a Loading Dose Initiate Oral Therapy in Adult Patients With Atrial Fibrillation) trial evaluates the safety feasibility intravenous (IV) sotalol, achieving steady state with maximum QTc prolongation within 6 hours instead traditional 5-dose inpatient oral (PO) titration.DASH-AF prospective, nonrandomized, multicenter, open-label consisting...

10.1016/j.jacep.2022.11.026 article EN cc-by JACC. Clinical electrophysiology 2023-02-22

Background: Data on outcomes of ST-elevation myocardial infarction (STEMI) in patients with cancer are scarce. We investigated the nationwide trends admissions for STEMI, utilization percutaneous coronary intervention (PCI), and in-hospital three most common diagnoses (lung, breast, colon) compared to without cancer. Methods: conducted an administrative database study using Nationwide Inpatient Sample (NIS). All in-patient hospitalizations STEMI from 2001 2011 were identified. Patients...

10.21037/atm.2017.11.29 article EN Annals of Translational Medicine 2017-12-01
Coming Soon ...